R Squared’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
R Squared's AZN Position: Q2 2026 in Review
R Squared reduced its AstraZeneca (AZN) stake by 27% in Q2 2026, selling an estimated $138K and leaving 1,987 shares worth $377K. The position accounts for 0.2% of the portfolio, ranked #157.
R Squared first reported a position in AZN in Q4 2024 and has held it in 5 quarters since. The position peaked at $555K in Q4 2025. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- R Squared held 1,987 shares of AstraZeneca worth $377K as of Q2 2026.
- R Squared sold 736 AstraZeneca shares in Q2 2026, an estimated $138K.
- AstraZeneca made up 0.2% of R Squared's portfolio in Q2 2026, its #157 holding.
- R Squared first reported a position in AstraZeneca in Q4 2024 and has held it in 5 quarters since.
- R Squared's AstraZeneca position peaked at $555K in Q4 2025.
- 1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.